Analysis Metabolite Name Measured Value Units Gender Glycemic status Neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-97365Peak area normalizedmale Pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-122073Peak area normalizedmale Diabetic Neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-156895Peak area normalizedfemale Diabetic Neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-157961Peak area normalizedmale Diabetic Neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-160020Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-166801Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-174039Peak area normalizedmale Diabetic no neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-181227Peak area normalizedmale Diabetic no neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-186023Peak area normalizedmale Normoglycemic no neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-190720Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-198953Peak area normalizedmale Pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-205871Peak area normalizedmale Normoglycemic Neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-208323Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-209473Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-210472Peak area normalizedfemale Diabetic no neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-217300Peak area normalizedfemale Diabetic Neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-227531Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-232056Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-239502Peak area normalizedmale Diabetic Neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-241932Peak area normalizedfemale Diabetic no neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-246811Peak area normalizedmale Normoglycemic Neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-254328Peak area normalizedmale Pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-266977Peak area normalizedmale Pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-275845Peak area normalizedmale Diabetic no neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-279820Peak area normalizedmale Normoglycemic no neuropathy
Reversed phase NEGATIVE ION MODELINOLEIC ACID (M-H)-383170Peak area normalizedfemale Pre-diabetic Neuropathy

Return to search page
  logo